Tauziède-Espariat, A., Mehdi, L., Gareton, A., Laquerrière, A., Adle-Biassette, H., Polivka, M., . . . Lechapt-Zalcman, E. (2021). GATA3 is not a diagnostic biomarker of central nervous system paragangliomas. Human pathology, 118, 86-87. https://doi.org/10.1016/j.humpath.2021.01.004
Chicago Style (17th ed.) CitationTauziède-Espariat, Arnault, Leïla Mehdi, Albane Gareton, Annie Laquerrière, Homa Adle-Biassette, Marc Polivka, Dominique Cazals-Hatem, Pascale Varlet, and Emmanuèle Lechapt-Zalcman. "GATA3 Is Not a Diagnostic Biomarker of Central Nervous System Paragangliomas." Human Pathology 118 (2021): 86-87. https://doi.org/10.1016/j.humpath.2021.01.004.
MLA (9th ed.) CitationTauziède-Espariat, Arnault, et al. "GATA3 Is Not a Diagnostic Biomarker of Central Nervous System Paragangliomas." Human Pathology, vol. 118, 2021, pp. 86-87, https://doi.org/10.1016/j.humpath.2021.01.004.